Publication | Closed Access
A targeted theranostic platinum(iv) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation
96
Citations
16
References
2014
Year
Real-time MonitoringPharmaceutical ScienceEngineeringNanomedicineMedicinal ChemistryBioanalysisTheranosticsAnalytical ChemistryDrug MonitoringClinical ChemistryAggregation-induced EmissionTherapeutic Drug MonitoringTargeted Theranostic PlatinumBiochemistryDrug DevelopmentPharmacologyBiomolecular EngineeringDrug ActivationMedicineDrug DiscoveryPharmaceutical ResearchDrug Analysis
A targeted theranostic platinum(IV) prodrug based on a luminogen with aggregation-induced emission (AIE) characteristics was developed for selective and real-time monitoring of drug activation in situ.
| Year | Citations | |
|---|---|---|
Page 1
Page 1